Mariëlle van der Kaaij

Search results

• 2022

  In Vivo and Ex Vivo Mitochondrial Function in COVID-19 Patients on the Intensive Care Unit

  Streng, L. W. J. M., de Wijs, C. J., Raat, N. J. H., Specht, P. A. C., Sneiders, D., van der Kaaij, M., Endeman, H., Mik, E. G. & Harms, F. A., 20 Jul 2022, In: Biomedicines. 10, 7, 1746.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access

  File

  • In Vivo 100%
  • Mitochondrial Function 100%
  • Mitochondrial DNA 100%
  • Ex Vivo 100%
  • COVID-19 100%
  14 Citations (Scopus)

  35 Downloads (Pure)
• 2020

  Low-dose oncolytic adenovirus therapy overcomes tumor-induced immune suppression and sensitizes intracranial gliomas to anti-PD-1 therapy

  Belcaid, Z., Berrevoets, C., Choi, J., van Beelen, E., Stavrakaki, E., Pierson, T., Kloezeman, J., Routkevitch, D., van der Kaaij, M., van der Ploeg, A., Mathios, D., Sleijfer, S., Dirven, C., Lim, M., Debets, R. & Lamfers, M. L. M., 3 Feb 2020, In: Neuro-Oncology Advances. 2, 1, p. 1-12

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access

  File
  36 Citations (Scopus)

  28 Downloads (Pure)

• A co-formulation of interferons type I and II enhances temozolomide response in glioblastoma with unmethylated MGMT promoter status

  Vázquez-Blomquist, D., Leenstra, S., van der Kaaij, M., Villarreal, A. & Bello-Rivero, I., 2020, In: Molecular Biology Reports. 47, 7, p. 5263-5271 9 p.

  Research output: Contribution to journal › Article › Academic › peer-review
  2 Citations (Scopus)
• 2016

  A Systematic Comparison Identifies an ATP-Based Viability Assay as Most Suitable Read-Out for Drug Screening in Glioma Stem-Like Cells

  Kleijn, A., Kloezeman, J., Balvers, R., van der Kaaij, M., Dirven, C., Leenstra, S. & Lamfers, M., 2016, In: Stem Cells International.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access

  File
  20 Citations (Scopus)

  18 Downloads (Pure)

• TP53 mutated glioblastoma stem-like cell cultures are sensitive to dual mTORC1/2 inhibition while resistance in TP53 wild type cultures can be overcome by combined inhibition of mTORC1/2 and Bcl-2

  Venkatesan, S., Hoogstraat, M., Caljouw, E., Pierson, T., Spoor, J., Moradi - Zeneyedpour, L., Dubbink, E. J., Dekker, L., van der Kaaij, M., Kloezeman, J., Berghauser Pont, L., Besselink, N. J. M., Luider, T., Joore, J., Martens, J., Lamfers, M., Sleijfer, S. & Leenstra, S., 2016, In: Oncotarget. 7, 36, p. 58435-58444 10 p.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access

  File
  9 Citations (Scopus)

  15 Downloads (Pure)